» Articles » PMID: 3970138

Phenotypic Expression of Hodgkin's and Reed-Sternberg Cells in Hodgkin's Disease

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1985 Feb 1
PMID 3970138
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

The phenotypic expression of Hodgkin's and Reed-Sternberg (H-RS) cells was determined by analysis with a panel of monoclonal antibodies and peanut agglutinin (PNA) by an immunohistochemical technique. Seven antibodies, including T200, anti-HLA-DR, anti-Leu 10, A1G3, anti-Tac, OKT9, and anti-Leu M1, were found to react with a great majority of H-RS cells. In some cases, H-RS cells also bound PNA. Other antibodies, including those highly specific for T cells (eg, Lyt 3) and B cells (eg, B1, anti-Leu 14) were consistently negative. The results argue against the derivation of H-RS cells from T or B lymphocytes. The H-RS cells were also negatively stained with antibodies which react with monocytes (OKM1, Mo-2, 63D-3), follicular dendritic cells (DRC-1), and natural killer/killer cells (Leu 7, Leu 11a, B73.1). The presence of Leu M1 and Tac in H-RS cells is of interest. Anti-Leu M1 positivity was seen in all 20 of Hodgkin's disease (HD) cases tested and should provide a very useful reagent for differential diagnosis of HD from other reactive and neoplastic conditions. Tac normally is present only on activated T cells. The presence of Tac in H-RS cells may reflect expression of T-cell growth factor receptor or a closely related protein during a stage of neoplastic transformation. Although the nature of the neoplastic cell of HD cannot be determined by these studies, they are consistent with an origin from interdigitating reticulum cells. Both H-RS cells and interdigitating reticulum cells have a similar antigenic phenotype (Leu M1+, T200+, HLA-DR+, Leu 10+, A1G3+, and OKT9+) and a similar pattern of lysosomal enzyme activity.

Citing Articles

The Need for Standardization in Next-Generation Sequencing Studies for Classic Hodgkin Lymphoma: A Systematic Review.

Santisteban-Espejo A, Bernal-Florindo I, Perez-Requena J, Atienza-Cuevas L, Moran-Sanchez J, Fernandez-Valle M Diagnostics (Basel). 2022; 12(4).

PMID: 35454013 PMC: 9027849. DOI: 10.3390/diagnostics12040963.


90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.

Janik J, Morris J, OMahony D, Pittaluga S, Jaffe E, Redon C Proc Natl Acad Sci U S A. 2015; 112(42):13045-50.

PMID: 26438866 PMC: 4620907. DOI: 10.1073/pnas.1516107112.


Classification of lymphoid neoplasms: the microscope as a tool for disease discovery.

Jaffe E, Lee Harris N, Stein H, Isaacson P Blood. 2008; 112(12):4384-99.

PMID: 19029456 PMC: 2954680. DOI: 10.1182/blood-2008-07-077982.


Receptor-directed therapy of T-cell leukemias and lymphomas.

Morris J, Waldmann T, Janik J J Immunotoxicol. 2008; 5(2):235-48.

PMID: 18569395 PMC: 7243878. DOI: 10.1080/15476910802129661.


Biological significance of soluble IL-2 receptor.

Caruso C, Candore G, Cigna D, Colucci A, Modica M Mediators Inflamm. 1993; 2(1):3-21.

PMID: 18475497 PMC: 2365387. DOI: 10.1155/S0962935193000018.


References
1.
Andersson L, Gahmberg C, Nilsson K, Wigzell H . Surface glycoprotein patterns of normal and malignant human lymphoid cells. I. T cells T blasts and leukemic T cell lines. Int J Cancer. 1977; 20(5):702-7. DOI: 10.1002/ijc.2910200509. View

2.
Rausch E, Kaiserling E, Goos M . Langerhans cells and interdigitating reticulum cells in the thymus-dependent region in human dermatopathic lymphadenitis. Virchows Arch B Cell Pathol. 1977; 25(4):327-43. DOI: 10.1007/BF02889443. View

3.
Pinkus G, Barbuto D, Said J, Churchill W . Lymphocyte subpopulations of lymph nodes and spleens in Hodgkin's disease. Cancer. 1978; 42(3):1270-9. DOI: 10.1002/1097-0142(197809)42:3<1270::aid-cncr2820420336>3.0.co;2-t. View

4.
Ree H, Song J, Leone L, Crowley J, FANGER H . Occurrence and patterns of muramidase containing cells in Hodgkin's disease, non-Hodgkin's lymphomas, and reactive hyperplasia. Hum Pathol. 1981; 12(1):49-59. DOI: 10.1016/s0046-8177(81)80241-9. View

5.
Uchiyama T, Broder S, Waldmann T . A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol. 1981; 126(4):1393-7. View